OAK RIDGE INVESTMENTS LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
OAK RIDGE INVESTMENTS LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$11,053,000
-66.4%
3,140,071
-4.6%
0.26%
-62.1%
Q2 2015$32,851,000
-21.5%
3,291,711
+0.1%
0.70%
-25.7%
Q1 2015$41,841,000
-9.0%
3,286,844
+1.2%
0.94%
-14.4%
Q4 2014$45,959,000
+2.4%
3,247,990
-0.5%
1.10%
-6.3%
Q3 2014$44,874,000
+40.2%
3,263,528
+56.8%
1.17%
+53.7%
Q2 2014$32,012,000
-9.1%
2,081,792
+0.7%
0.76%
-14.0%
Q1 2014$35,223,0002,067,0530.88%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders